• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
Trump Critical of FDA Decision to Revoke Emergency Use of Drug He Has Promoted for COVID-19

Trump Critical of FDA Decision to Revoke Emergency Use of Drug He Has Promoted for COVID-19

June 16, 2020
LARRY PROVOST: President Trump Stamps Out Calhoun’s Legacy Of Insurrection And Nullification

LARRY PROVOST: President Trump Stamps Out Calhoun’s Legacy Of Insurrection And Nullification

June 16, 2025
Trump Issues Ominous Warning To Iran

Trump Issues Ominous Warning To Iran

June 16, 2025
EXCLUSIVE: How Chinese Intel Infiltrated LA Mayor Karen Bass’ Camp

EXCLUSIVE: How Chinese Intel Infiltrated LA Mayor Karen Bass’ Camp

June 16, 2025
EXCLUSIVE — ‘Something For Every American’: Speaker Johnson Touts ‘America First’ Wins In Trump’s Megabill

EXCLUSIVE — ‘Something For Every American’: Speaker Johnson Touts ‘America First’ Wins In Trump’s Megabill

June 16, 2025
JD FOSTER: Senator Paul Is Mostly Right And A Little Wrong About The Big, Beautiful Bill

JD FOSTER: Senator Paul Is Mostly Right And A Little Wrong About The Big, Beautiful Bill

June 16, 2025
EXCLUSIVE: University Consultants Debated Creating ‘LGBTQ+ Church’ To Skirt Trump’s Orders

EXCLUSIVE: University Consultants Debated Creating ‘LGBTQ+ Church’ To Skirt Trump’s Orders

June 16, 2025
VIJAY JAYARAJ:  Big, Beautiful Coal Here For Many More Years Despite ‘Green’ Demonization

VIJAY JAYARAJ: Big, Beautiful Coal Here For Many More Years Despite ‘Green’ Demonization

June 16, 2025
California Demands Federal Tax Dollars For High-Speed Rail Boondoggle

California Demands Federal Tax Dollars For High-Speed Rail Boondoggle

June 16, 2025
EXCLUSIVE: Thune Says Senate GOP Has Plan To Fight Back Against Activist Judges

EXCLUSIVE: Thune Says Senate GOP Has Plan To Fight Back Against Activist Judges

June 16, 2025
White Wisconsin Dairy Farmer Sues USDA For Holding Out On Axing Biden-Era DEI Programs

White Wisconsin Dairy Farmer Sues USDA For Holding Out On Axing Biden-Era DEI Programs

June 16, 2025
Israel Not Interested In Peace Talks With Iran, Netanyahu Says

Israel Not Interested In Peace Talks With Iran, Netanyahu Says

June 16, 2025
Trump Cans Biden’s Nuclear Regulator As Agency Faces Pro-Nuke Overhaul

Trump Cans Biden’s Nuclear Regulator As Agency Faces Pro-Nuke Overhaul

June 16, 2025
  • Donald Trump
  • State of the Union
  • Elon Musk
  • Tariffs
  • Congress
  • Faith
  • Immigration
Monday, June 16, 2025
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

Trump Critical of FDA Decision to Revoke Emergency Use of Drug He Has Promoted for COVID-19

by Reuters
June 16, 2020
in News
250 2
3
Trump Critical of FDA Decision to Revoke Emergency Use of Drug He Has Promoted for COVID-19

George Frey/File Photo/Reuters

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The U.S. Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat COVID-19, but quickly came under fire from President Donald Trump, who said only U.S. agencies have failed to grasp its benefit in fighting the coronavirus.

Based on new evidence, the FDA said it was no longer reasonable to believe that hydroxychloroquine and the related drug chloroquine may be effective in treating the illness caused by the novel coronavirus.

The FDA also warned that the drugs have been shown in lab studies to interfere with Gilead Sciences Inc’s antiviral drug remdesivir – the only medicine so far to show a benefit against COVID-19 in formal clinical trials.

The move comes after several studies of the decades-old malaria pills suggested they were not effective either as a treatment for or to prevent COVID-19.

British scientists earlier this month halted a large trial after deciding that hydroxychloroquine was “useless” at treating COVID-19 patients.

Hydroxychloroquine’s anti-inflammatory and antiviral properties suggested it might help COVID-19 patients, and the FDA authorized its emergency use in March at the height of a pandemic for which there were no approved treatments.

The early enthusiasm was partly based on laboratory experiments in which the drug appeared to neutralize the virus. Chloroquine, which is not approved for any use in the United States and has more side effects, has not fared any better in human clinical trials.

In March, Trump said hydroxychloroquine in combination with the antibiotic azithromycin had “a real chance to be one of the biggest game changers in the history of medicine,” with little evidence to back up that claim.

He later said he took the drugs preventively after two people who worked at the White House were diagnosed with COVID-19, and he urged others to try it.

“I took it and I felt good about taking it. I don’t know if it had an impact, but it certainly didn’t hurt me,” Trump said on Monday.

Trump said there had been “great reports” out of France, Spain and other places, without offering any evidence or further explanation. France is one of the countries that has already stopped using the drug for COVID-19 patients.

U.S. Secretary of Health and Human Services Alex Azar said the drug is still being studied for possible use at an earlier stage of the disease.

“A lot of the data that has come out that was more negative was people who were quite ill in the hospital,” he said.

The drug can still be used with a doctor’s prescription, Azar noted. Any drug with U.S. approval can be used in any way a doctor sees fit regardless of what it has been approved for.

DRUG’S USE ALREADY IN DECLINE

Doctors in recent weeks had already pulled back on the use of hydroxychloroquine for COVID-19, after several studies suggested it is not effective and may pose heart risks for certain patients.

The Infectious Diseases Society of America on Monday backed the FDA decision “to revoke emergency use authorization for hydroxychloroquine and chloroquine.”

Half of hospitals responding to a mid-May survey conducted by the American Society of Health-System Pharmacists (ASHP) reported excess supplies of hydroxychloroquine that they expected to return to wholesalers.

Current U.S. government treatment guidelines do not recommend its use for COVID-19 patients outside of a clinical trial.

France, Italy and Belgium late last month halted use of hydroxychloroquine for COVID-19 patients. But the United States last month sent 2 million doses to Brazil, which has emerged as the pandemic’s latest epicenter.

Hundreds of trials testing hydroxychloroquine or chloroquine as interventions for COVID-19 are still underway, including a U.S. study designed to show whether hydroxychloroquine in combination with azithromycin can prevent hospitalization and death from COVID-19.

(Reporting by Manas Mishra in Bengaluru and Deena Beasley in Los Angeles; Additional reporting by Jeff Mason in Washington; Editing by Bill Berkrot)

Tags: Coronavirus OutbreakDonald TrumpFood and Drug Administration
Share196Tweet123
Reuters

Reuters

Reuters is an international news organization.

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th